High Risk of Sustained Ventricular Arrhythmia Recurrence After Acute Myocarditis

Overview

Journal J Clin Med

Specialty General Medicine

Date 2020 Apr 5

PMID 32244983

Citations 12

Authors

Laurent Rosier

Amir Zouaghi

Valentin Barre

Raphael Martins

Vincent Probst

Eloi Marijon

Nicolas Sadoul

Samuel Chauveau

Antoine Da Costa

Marc Badoz

Michael Peyrol

Jeremie Barraud

Gregoire Massoullie

Romain Eschalier

Madeline Espinosa

Francois Lesaffre

Rodrigue Garcia

Bruno Degand

Antoine Noel

Jacques Mansourati

Fabrice Extramiana

Vincent Algalarrondo

Herve Devilliers

Yves Cottin

Estelle Gandjbakhch

Charles Guenancia

Affiliations

Soon will be listed here.

Abstract

Acute myocarditis is associated with cardiac arrhythmia in 25% of cases; a third of these arrhythmias are ventricular tachycardia (VT) or ventricular fibrillation (VF). The implantation of a cardiac defibrillator (ICD) following sustained ventricular arrhythmia remains controversial in these patients. We sought to assess the risk of major arrhythmic ventricular events (MAEs) over time in patients implanted with an ICD following sustained VT/VF in the acute phase of myocarditis compared to those implanted for VT/VF occurring on myocarditis sequelae. Our retrospective observational study included patients implanted with an ICD following VT/VF during acute myocarditis or VT/VF on myocarditis sequelae, from 2007 to 2017, in 15 French university hospitals. Over a median follow-up period of 3 years, MAE occurred in 11 (39%) patients of the acute myocarditis group and 24 (60%) patients of the myocarditis sequelae group. Kaplan-Meier MAE rate estimates at one and three years of follow-up were 19% and 45% in the acute group, and 43% and 64% in the sequelae group. Patients who experienced sustained ventricular arrhythmias during acute myocarditis had a very high risk of VT/VF recurrence during follow-up. These results show that the risk of MAE recurrence remains high after resolution of the acute episode.

Citing Articles

Sudden cardiac death after acute myocarditis with arrhythmic presentation: hunting for risk predictors - a systematic review and meta-analysis.

Narducci M, Ballacci F, Giordano F, Collini V, Imazio M Open Heart. 2025; 11(2).

PMID: 39882569 PMC: 11603706. DOI: 10.1136/openhrt-2024-002985.

Management of patient with acute lymphocytic myocarditis and congenital long QT syndrome presenting with electrical storm and incessant Torsade de Pointes: a case report.

Karwiky G, Pranata R, Undarsa A, Iqbal M, Prameswari H, Akbar M J Med Case Rep. 2024; 18(1):603.

PMID: 39702342 PMC: 11660443. DOI: 10.1186/s13256-024-04919-z.

Transient Left Ventricular Dysfunction from Cardiomyopathies to Myocardial Viability: When and Why Cardiac Function Recovers.

Trimarchi G, Teresi L, Licordari R, Pingitore A, Pizzino F, Grimaldi P Biomedicines. 2024; 12(5).

PMID: 38791012 PMC: 11117605. DOI: 10.3390/biomedicines12051051.

Update on Myocarditis: From Etiology and Clinical Picture to Modern Diagnostics and Methods of Treatment.

Lasica R, Djukanovic L, Savic L, Krljanac G, Zdravkovic M, Ristic M Diagnostics (Basel). 2023; 13(19).

PMID: 37835816 PMC: 10572782. DOI: 10.3390/diagnostics13193073.

Use of the Wearable Cardioverter-Defibrillator Among Patients With Myocarditis and Reduced Ejection Fraction or Ventricular Tachyarrhythmia: Data From a Multicenter Registry.

El-Battrawy I, Koepsel K, Tenbrink D, Kovacs B, Dreher T, Blockhaus C J Am Heart Assoc. 2023; 12(18):e030615.

PMID: 37681569 PMC: 10547297. DOI: 10.1161/JAHA.123.030615.

References

Grani C, Eichhorn C, Biere L, Murthy V, Agarwal V, Kaneko K . Prognostic Value of Cardiac Magnetic Resonance Tissue Characterization in Risk Stratifying Patients With Suspected Myocarditis. J Am Coll Cardiol. 2017; 70(16):1964-1976. PMC: 6506846. DOI: 10.1016/j.jacc.2017.08.050. View

Pavlicek V, Kindermann I, Wintrich J, Mahfoud F, Klingel K, Bohm M . Ventricular arrhythmias and myocardial inflammation: Long-term follow-up of patients with suspected myocarditis. Int J Cardiol. 2018; 274:132-137. DOI: 10.1016/j.ijcard.2018.07.142. View

Adabag A, Maron B, Appelbaum E, Harrigan C, Buros J, Gibson C . Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance. J Am Coll Cardiol. 2008; 51(14):1369-74. DOI: 10.1016/j.jacc.2007.11.071. View

van Welsenes G, van Rees J, Borleffs C, Cannegieter S, Bax J, van Erven L . Long-term follow-up of primary and secondary prevention implantable cardioverter defibrillator patients. Europace. 2011; 13(3):389-94. DOI: 10.1093/europace/euq494. View

Anzini M, Merlo M, Sabbadini G, Barbati G, Finocchiaro G, Pinamonti B . Long-term evolution and prognostic stratification of biopsy-proven active myocarditis. Circulation. 2013; 128(22):2384-94. DOI: 10.1161/CIRCULATIONAHA.113.003092. View

Grun S, Schumm J, Greulich S, Wagner A, Schneider S, Bruder O . Long-term follow-up of biopsy-proven viral myocarditis: predictors of mortality and incomplete recovery. J Am Coll Cardiol. 2012; 59(18):1604-15. DOI: 10.1016/j.jacc.2012.01.007. View

Saito J, Niwano S, Niwano H, Inomata T, Yumoto Y, Ikeda K . Electrical remodeling of the ventricular myocardium in myocarditis: studies of rat experimental autoimmune myocarditis. Circ J. 2002; 66(1):97-103. DOI: 10.1253/circj.66.97. View

Caforio A, Calabrese F, Angelini A, Tona F, Vinci A, Bottaro S . A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and aetiopathogenetic features at diagnosis. Eur Heart J. 2007; 28(11):1326-33. DOI: 10.1093/eurheartj/ehm076. View

Aquaro G, Perfetti M, Camastra G, Monti L, Dellegrottaglie S, Moro C . Cardiac MR With Late Gadolinium Enhancement in Acute Myocarditis With Preserved Systolic Function: ITAMY Study. J Am Coll Cardiol. 2017; 70(16):1977-1987. DOI: 10.1016/j.jacc.2017.08.044. View

10.

Assomull R, Prasad S, Lyne J, Smith G, Burman E, Khan M . Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol. 2006; 48(10):1977-85. DOI: 10.1016/j.jacc.2006.07.049. View

11.

Mahrholdt H, Wagner A, Judd R, Sechtem U, Kim R . Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. Eur Heart J. 2005; 26(15):1461-74. DOI: 10.1093/eurheartj/ehi258. View

12.

Friedrich M, Sechtem U, Schulz-Menger J, Holmvang G, Alakija P, Cooper L . Cardiovascular magnetic resonance in myocarditis: A JACC White Paper. J Am Coll Cardiol. 2009; 53(17):1475-87. PMC: 2743893. DOI: 10.1016/j.jacc.2009.02.007. View

13.

Di Marco A, Anguera I, Schmitt M, Klem I, Neilan T, White J . Late Gadolinium Enhancement and the Risk for Ventricular Arrhythmias or Sudden Death in Dilated Cardiomyopathy: Systematic Review and Meta-Analysis. JACC Heart Fail. 2016; 5(1):28-38. DOI: 10.1016/j.jchf.2016.09.017. View

14.

Bruder O, Wagner A, Jensen C, Schneider S, Ong P, Kispert E . Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2010; 56(11):875-87. DOI: 10.1016/j.jacc.2010.05.007. View

15.

Mahrholdt H, Goedecke C, Wagner A, Meinhardt G, Athanasiadis A, Vogelsberg H . Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation. 2004; 109(10):1250-8. DOI: 10.1161/01.CIR.0000118493.13323.81. View

16.

Lang R, Bierig M, Devereux R, Flachskampf F, Foster E, Pellikka P . Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of.... J Am Soc Echocardiogr. 2005; 18(12):1440-63. DOI: 10.1016/j.echo.2005.10.005. View

17.

Cocker M, Abdel-Aty H, Strohm O, Friedrich M . Age and gender effects on the extent of myocardial involvement in acute myocarditis: a cardiovascular magnetic resonance study. Heart. 2009; 95(23):1925-30. DOI: 10.1136/hrt.2008.164061. View

18.

Priori S, Blomstrom-Lundqvist C, Mazzanti A, Blom N, Borggrefe M, Camm J . 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the.... Eur Heart J. 2015; 36(41):2793-2867. DOI: 10.1093/eurheartj/ehv316. View

19.

Peretto G, Sala S, Rizzo S, Luca G, Campochiaro C, Sartorelli S . Arrhythmias in myocarditis: State of the art. Heart Rhythm. 2018; 16(5):793-801. DOI: 10.1016/j.hrthm.2018.11.024. View

20.

Coronado M, Brandt J, Kim E, Bucek A, Bedja D, Abston E . Testosterone and interleukin-1β increase cardiac remodeling during coxsackievirus B3 myocarditis via serpin A 3n. Am J Physiol Heart Circ Physiol. 2012; 302(8):H1726-36. PMC: 3330806. DOI: 10.1152/ajpheart.00783.2011. View